Drew Pardoll as a keynote speaker at NFCR’s Global Summit

National Foundation for Cancer Research (NFCR) shared on LinkedIn:

“As we approach our Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship, we’re excited to start highlighting our incredible keynote speakers and awardees! We are kicking off the series by highlighting Drew Pardoll.

Stay tuned as we count down to this inspiring event, celebrating groundbreaking innovations and achievements in the fight against cancer.”

Source: NFCR/LinkedIn

Other posts featuring NFCR on OncoDaily.

Drew Pardoll is the Abeloff Professor of Oncology, Medicine, Pathology, and Molecular Biology and Genetics at Johns Hopkins University School of Medicine. He serves as the Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy and Co-Director of the Cancer Immunology Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He has authored over 300 articles on topics including cancer vaccines, gene therapies, cancer prevention technologies, and recombinant immune modulatory agents targeting pathways that regulate immunity in cancer and infectious diseases.